Gout
Conference Coverage
Allopurinol proves noninferior to febuxostat for gout relief
A randomized, treat-to-target trial showed that the two urate-lowering therapies were comparably effective and safe at doses titrated to target,...
From the Journals
U.S. arthritis prevalence continues steady rise; activity limitations grow more rapidly
The latest survey data indicated that more Americans have arthritis than ever before, possibly because of an aging population, worsening...
Conference Coverage
Two swings, two misses with colchicine, Vascepa in COVID-19
The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.
Conference Coverage
Western and proinflammatory diets are important drivers of gout risk
Western and proinflammatory diets are associated with increased risk of gout independent of other factors.
From the Journals
Rheumatology clinics find success with smoking cessation referral program
Clinics that adopted a protocolized, EHR-based approach to checking for readiness to quit saw a 26-fold increase in quit-line referrals.
From the Journals
Febuxostat, allopurinol real-world cardiovascular risk appears equal
Medicare claims data from gout patients in 2008-2016 corroborate recent reports on febuxostat’s cardiovascular safety and all-cause mortality data...
From the Journals
COVID-19 vaccination in RMD patients: Safety data “reassuring”
Two studies show mainly mild reactions and favorable antibody responses in patients with rheumatic and musculoskeletal diseases after vaccination...
Feature
RECOVERY trial of COVID-19 treatments stops colchicine arm
Recruitment was halted for lack of efficacy in patients hospitalized with the disease.
Guidelines
COVID-19 vaccination recommended for rheumatology patients
The threat posed by COVID-19 for people with rheumatic diseases outweighs concerns about vaccination against SARS-CoV-2, says the American College...
From the Journals
ColCORONA: More questions than answers for colchicine in COVID-19
Millions of dollars and thousands of patients later, the phase 3 study highlights the challenges of COVID-19–related preprint studies without peer...
From the Journals
Rheumatologic disease activity an important influencer of COVID-19 death risk
COVID-19 Global Rheumatology Alliance physician registry data highlight need to maintain adequate disease control to lower risk for death from...